LAVAL, QC / ACCESSWIRE / May 14, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology business Salix Pharmaceuticals, today announced certain updates related to its litigation with Norwich Pharmaceuticals, Inc.With respect to the April 11, 2024, decision of the US Court of Appeals for the...

Related Keywords

New Jersey , United States , Canada , Canadian , Garen Sarafian , Kevin Wiggins , Norwich Pharmaceuticals Inc , Linkedin , Twitter , Exchange Commission , Us Court , Bausch Health , Drug Administration , Bausch Health Companies Inc , Salix Pharmaceuticals , Bausch Health Companies , Norwich Pharmaceuticals , Federal Circuit , Abbreviated New Drug Application , Health Companies , Canadian Securities Administrators ,